ELIZABETH PFEIFER: Open Payments
NPI 1124801337 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 56 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $479 |
| ABBVIE INC. | 13 | $468 |
| Lilly USA, LLC | 14 | $447 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $302 |
| PFIZER INC. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $9 |
Products named: TREMFYA, OMVOH, ENTYVIO, RINVOQ, SKYRIZI, VELSIPITY, XIFAXAN.
Industry payments across IN — which companies pay providers there.
